Different effects of atenolol and nebivolol on coronary flow reserve

Heart

Volumn 92, Issue 11, 2006, Pages 1690-1691

  Gullu, Hakan ^a   Erdogan, D ^a   Caliskan, M ^a   Tok, D ^a   Yildirim, I ^a   Sezgin, A T ^a   Muderrisoglu, H ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; NEBIVOLOL;

ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE FILLING; HEART RATE; HUMAN; HYPEREMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BENZOPYRANS; CORONARY CIRCULATION; ETHANOLAMINES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE;

EID: 33750284959     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.084079     Document Type: Article

References (6)

1. Tzemos N, Lim PO, MacDonald TM. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study. Circulation 2001;104:511-4.
2. Lambertz H, Tries HP, Stein T, et al. Noninvasive assessment of coronary flow reserve with transthoracic signal-enhanced Doppler echocardiography. J Am Soc Echocardiogr 1999;12:186-95.
3. Dawes M, Brett SE, Chowienczyk PJ, et al. The vasodilator action of nebivolol in forearm vasculature of subjects with essential hypertension. Br J Clin Pharmacol 1999;48:460-3.
4. Brush JE Jr, Cannon RO 3rd, Schenke WH, et al. A. gina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. N Engl J Med 1988;319:1302-7.
5. Galderisi M, Cicala S, D'Errico A, et al. Nebivolol improves coronary flow reserve in hypertensive patients without coronary heart disease. J Hypertens 2004;22:2201-8.
6. Zeiher AM, Krause T, Schachinger V, et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345-52.